ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Pliant Receives FDA Orphan Drug Designation for PLN-74809
fiercebiotech
August 07, 2018Pliant Therapeutics announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's anti-fibrotic lead compound, PLN-74809, for the treatment of idiopathic pulmonary fibrosis (IPF).
Pharma Sources Insight January 2025
